Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock par value $0.001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
7.65M
-
Shares change
-
+606K
-
Total reported value, excl. options
-
$59.7M
-
Value change
-
+$4.81M
-
Number of buys
-
28
-
Number of sells
-
-19
-
Price
-
$7.80
Significant Holders of Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) as of Q2 2018
56 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock par value $0.001 per share as of Q2 2018.
Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.65M shares
of 134M outstanding shares and own 5.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.48M shares), FMR LLC (1.31M shares), COWEN INC. (663K shares), Tekla Capital Management LLC (536K shares), VANGUARD GROUP INC (445K shares), OppenheimerFunds, Inc. (425K shares), JENNISON ASSOCIATES LLC (394K shares), DEUTSCHE BANK AG\ (305K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (285K shares), and Granite Point Capital Management, L.P. (279K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.